Searchable abstracts of presentations at key conferences in endocrinology

ea0011p156 | Clinical case reports | ECE2006

17beta-hydroxysteroid dehydrogenase deficiency caused by homozygous h271r mutation

Bachelot A , Chakhtoura Z , Kuttenn F , Morel Y , Touraine Ph

17β-hydroxysteroid dehydrogenase-3 (17βHSD3) deficiency is an autosomal recessive form of male pseudohermaphroditism due to impaired testicular conversion of androstenedione to testosterone. 46,XY homozygotes or compound heterozygotes for mutations of the HSD17B3 gene have testes and normally developed Wolffian duct derivatives, but they present with undervirilization of the external genitalia, which are often female. About twenty different mutations of the 17βH...

ea0020p645 | Reproduction | ECE2009

A monocentric study of 360 consecutive patients presenting with premature ovarian failure

Bachelot Anne , Rouxel Agnes , Massin Nathalie , Dulon Jerome , Courtillot Carine , Kuttenn Frederique , Touraine Philippe

Premature ovarian failure (POF) encompasses a heterogeneous spectrum of conditions, with phenotypic variability among patients. The etiology of POF remains unknown in most cases. This led us to set up a French network on POF for the purpose of better characterizing POF patients and understanding the mechanisms involved in this pathology. Over the last 10 years, we have evaluated 360 women who were referred to our center with a diagnosis of POF, and performed a study of clinica...

ea0011s36 | Clinical lessons from novel aspects of G protein-coupled receptors signalling | ECE2006

Moleular pathology of the FSH receptor

Vasseur C , Rodien P , Meduri G , Touraine P , Lahuna O , Kuttenn F , Misrahi M

The identification of naturally occurring genetic mutations of the FSH receptor has led to a better understanding of the role of FSH in folliculogenesis and has allowed to identify the cause of several syndroms. Inactivating mutations of the follicle stimulating hormone (FSH) receptor have been described in rare cases of premature ovarian failure (POF). We have studied a new patient presenting a complete POF phenotype, with high plasma FSH levels, very low estrogen and inhibin...

ea0016p18 | Adrenal | ECE2008

Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency

Zeina Chakhtoura , Anne Bachelot , Dinane Samara-Boustani , Jean-Charles Ruiz , Bruno Donadille , Jerome Dulon , Sophie Christin-Maitre , Claire Bouvattier , Marie-Charles Raux-Demay , Philippe Bouchard , Jean-Claude Carel , Juliane Leger , Frederique Kuttenn , Michel Polak , Philippe Touraine

Introduction: There are contradictory results concerning bone mineral density status in adult patients with congenital adrenal hyperplasia. To resolve this issue, we hypothesized that there could be a correlation between BMD and a total cumulative glucocorticoid dose from the diagnosis in early infancy to adulthood. We then conducted a retrospective in a referral centers for CAH. Thirty-eight adult patients (28 women, 10 men, aged 16–39 years) suffering from CAH and treat...